Virt-Select Prenatal/Postnatal Softgels — Class III drug recall D-0240-2017
Terminated recall by VIRTUS PHARMACEUTICALS OPCO II L, reported 2017-01-04, distributed nationwide. cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.
| Recall number | D-0240-2017 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | VIRTUS PHARMACEUTICALS OPCO II L, Nashville, TN, United States |
| Recall initiated | 2016-12-12 |
| Classified | 2016-12-28 |
| Reported by FDA | 2017-01-04 |
| Terminated | 2018-08-21 |
| Distributed | Nationwide (US) |
| Quantity | 9,795 bottles |
| Reason classes | cgmp |
| NDC | 76439-0249-30 |
| Lot numbers | 21511153 |
| Expiration dates | 2017-10-30 |
Product
Virt-Select Prenatal/Postnatal Softgels, Prescription Multivitamin/Mineral Dietary Supplement with Fish-Based DHA , packaged in 30-count bottle, Rx only, Made in Canada, NDC 76439-249-30
Reason for recall
cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0240-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.